The unfolded protein response and cancer: A brighter future unfolding?

Journal of Molecular Medicine

Volumn 85, Issue 4, 2007, Pages 331-341

  Scriven, Peter ^a   Brown, Nicola J ^a   Pockley, A Graham ^a   Wyld, Lynda ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cancer; Heat shock proteins; Human disease; Stress response; Unfolded protein response

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; BUTYRIC ACID; CISPLATIN; DOCETAXEL; FR 901228; GEMCITABINE; PROTEIN; UNCLASSIFIED DRUG; VERSIPELOSTATIN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; CELL METABOLISM; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG TARGETING; INTERSTITIAL FLUID; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MAMMAL CELL; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PROSTATE CANCER; PROTEIN FOLDING; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STRUCTURAL PROTEOMICS; T CELL LEUKEMIA;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 33947402280     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0150-5     Document Type: Review

References (136)

1. Ritossa FM (1962) A new puffing pattern induced by temperature shock and DNP in Drosophila. Experientia 18:571-573
2. Ritossa FM (1963) New puffs induced by temperature shock, DNP and salicylate in salivary chromosomes of Drosophila melanogaster. Drosoph Inf Serv 37:122-123
3. Ritossa FM (1964) Specific loci in polytene chromosomes of Drosophila. Exp Cell Res 35:601-607
4. Tissières A, Mitchell HK, Tracy U (1974) Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs. J Mol Biol 84:389-398
5. Subjeck JR, Shyy T, Shen J, Johnson RJ (1983) Association between mammalian 110,000 dalton heat shock protein and nucleoli. J Cell Biol 97:1389-1398
6. Hattori H, Liu Y-C, Tohnai I, Ueda M, Kaneda T, Kobayashi T, Tanabe K, Ohtsuka K (1992) Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells. Cell Struct Funct 17:77-86
7. Hattori H, Kaneda T, Lokeshwar B, Laszlo A, Ohtsuka K (1993) A stress-inducible 40 kDa protein (hsp40): purification by modified two-dimensional gel electrophoresis and colocalization with hsc70(p73) in heat-shocked HeLa cells. J Cell Sci 104:629-638
8. Nagata K, Saga S, Yamada KM (1986) A major collagen-binding protein of chicken embryo fibroblasts is a novel heat shock protein. J Cell Biol 103:223-229
9. Hartman DJ, Hoogenraad NJ, Condron R, Hoj PB (1992) Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro. Proc Natl Acad Sci USA 89:3394-3398
10. Kopecek P, Altmannova K, Weigl E (2001) Stress proteins: nomenclature, divisions and functions. Biomed Pap Med Fac Univ Palacky Univ Olomouc Czech Repub 145:39-47
11. Lee AS (1987) Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem Sci 12:20-23
12. Chao CC, Yam WC, Lin-Chao S (1990) Coordinated induction of two unrelated glucose regulated protein genes by a calcium ionophore: human BiP/GRP78 and GAPDH. Biochem Biophys Res Commun 171:431-438
13. Whelan SA, Hightower LE (1985) Differential induction of glucose regulated and heat shock proteins: effects of pH and sulfhydryl reducing agents on chicken embryo cells. J Cell Physiol 125:251-258
14. Sciandra JJ, Subjeck JR, Hughes CS (1984) Induction of glucose regulated proteins during anaerobic exposure and of heat shock proteins after reoxygenation. Proc Natl Acad Sci USA 81:4843-4847
15. Shiu RPC, Pouyssegur J, Pastan I (1977) Glucose depletion accounts for the induction of two transformation sensitive membrane proteins in Rous Sarcoma Virus transformed chick embryo fibroblasts. Proc Natl Acad Sci USA 74:3840-3844
16. Haas IG, Wabl M (1983) Immunoglobulin heavy chain binding protein. Nature 306:387-389
17. Roll DE, Murphy BJ, Laderoute KR, Sutherland RM, Smith HC (1991) Oxygen regulated 80 kDa protein and glucose regulated 78 kDa protein are identical. Mol Cell Biochem 103:141-148
18. Munro S, Pelham HR (1986) An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46:291-300
19. Dorner AJ, Bole DG, Kaufman RJ (1987) The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol 105:2665-2674
20. Chang SC, Wooden SK, Nakaki T, Kim YK, Lin AY, Kung L, Attenello JW, Lee AS (1987) Rat gene encoding the 78-kDa glucose-regulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression. Proc Natl Acad Sci USA 84:680-684
21. Machamer CE, Doms RW, Bole DG, Helenius A, Rose JK (1990) Heavy chain binding protein recognizes incompletely disulfide-bonded forms of vesicular stomatitis virus G protein. J Biol Chem 265:6879-6883
22. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J (1988) The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332:462-464
23. Watowich SS, Morimoto RI (1988) Complex regulation of heat shock-and glucose-responsive genes in human cells. Mol Cell Biol 8:393-405
24. Dorner AJ, Wasley LC, Kaufman RJ (1989) Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J Biol Chem 264:20602-20607
25. Lee AS (1992) Mammalian stress response; induction of the glucose-regulated protein family. Curr Opin Cell Biol 4:267-273
26. Tu BP, Weissman JS (2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164:341-346
27. Tirasophon W, Welihinda AA, Kaufman RJ (1998) A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev 12:1812-1824
28. Wang XZ, Harding HP, Zhang Y, Jolicoeur EM, Kuroda M, Ron D (1998) Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J 17:5708-5717
29. Iwawaki T, Hosoda A, Okuda T, Kamigori Y, Nomura-Furuwatari C, Kimata Y, Tsuru A, Kohno K (2001) Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. Nat Cell Biol 3:158-164
30. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2:326-332
31. Bertolotti A, Wang X, Novoa I, Jungreis R, Schlessinger K, Cho JH, West AB, Ron D (2001) Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice. J Clin Invest 107:585-593
32. Bertolotti A, Ron DA (2001) Alterations in an IRE1-RNA complex in the mammalian unfolded protein response. J Cell Sci 114:3207-3212
33. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891
34. Lee AH, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23:7448-7459
35. Calfon M, Zeng H, Urano F, Till JH, Hubbard RS, Harding HP, Clark SG, Ron D (2002) IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP1 mRNA. Nature 415:92-96
36. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayma T, Tohyama M (2001) Activation of caspase 12, an endoplasmic reticulum (ER) resident caspase, through tumour necrosis factor receptor associated factor 2 dependent mechanism in response to the ER stress. J Biol Chem 276:13935-13940
37. Nakagawa T, Zhu H, Morishima M, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic reticulum specific apoptosis and cytotoxicity by amyloid β. Nature 403:98-103
38. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S, Nicholson DW (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429:75-79
39. Nawrocki ST, Carew JS, Dunner K Jr, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ (2005) Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 65:11510-11519
40. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y, Tohyama M (2004) Involvement of caspase-4 in endoplasmic reticulum stress induced apoptosis and Aβ induced cell death. J Cell Biol 165:347-356
41. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H (2002) ASK1 is essential for endoplasmic reticulum stress induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16:1345-1355
42. 2/M. Mol Cell Biol 19:8469-8478
43. Lei K, Davis RJ (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100:2432-2437
44. Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antonsson B, Brandt GS, Iwakoshi NN, Schinzel A, Glimcher LH, Korsmeyer SJ (2006) Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1α. Science 312:572-576
45. Shi Y, Vattem KM, Sood R, An J, Liang J, Stramm L, Wek RC (1998) Identification and characterization of pancreatic eukaryotic initiation factor 2 α-subunit kinase, PEK, involved in translational control. Mol Cell Biol 18:7499-7509
46. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic reticulum-resident kinase. Nature 397:271-274
47. Hinnebusch AG (1994) The eIF-2α kinases: regulators of protein synthesis in starvation and stress. Semin Cell Biol 5:417-426
48. Brostrom CO, Brostrom MA (1998) Regulation of translational initiation during cellular responses to stress. Prog Nucleic Acid Res Mol Biol 58:79-125
49. Gulow K, Bienert D, Haas IG (2002) BiP is feed-back regulated by control of protein translational efficiency. J Cell Sci 115:2443-2452
50. Brewer JW, Diehl JA (2000) PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc Natl Acad Sci USA 97:2625-12630
51. Lu PD, Harding HP, Ron D (2004) Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol 167:27-33
52. van Huizen R, Martindale JL, Gorospe M, Holbrook NJ (2003) P58IPK, a novel endoplasmic reticulum stress-inducible protein and potential negative regulator of eIF2α signaling. J Biol Chem 278:15558-15564
53. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, Ron D (2000) Regulated translation initiation controls stress induced gene expression in mammalian cells. Mol Cell 6:1099-1108
54. Ma Y, Hendershot LM (2003) Delineation of the negative feedback regulatory loop that controls protein translation during ER stress. J Biol Chem 278:34864-34873
55. Ma Y, Brewer JW, Diehl JA, Hendershot LM (2002) Two distinct stress signalling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J Mol Biol 318:1351-1365
56. Haze K, Yoshida H, Yanagi H, Yura T, Mori K (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10:3787-3799
57. Ye J, Rawson RB, Komuro R, Chen X, Dave UP, Prywes R, Brown MS, Goldstein JL (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 6:1355-1364
58. Ladiges WC, Knoblaugh SE, Morton JF, Korth MJ, Sopher BL, Baskin CR, MacAuley A, Goodman AG, LeBoeuf RC, Katze MG (2005) Pancreatic β-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes 54:1074-1081
59. Travers KJ, Patil CK, Wodicka L, Lockhart DJ, Weissman JS, Walter P (2000) Functional and genomic analyses reveal essential coordination between the unfolded protein response and endoplasmic reticulum associated degradation. Cell 101:249-258
60. McCracken AA, Bordsky JL (2000) A molecular portrait of the response to unfolded proteins. Genome Biology 1:10131.1-11013.3
61. Kabani M, Kelley SS, Morrow MW, Montgomery DL, Sivendran R, Rose MD, Gierasch LM, Brodsky JL (2003) Dependence of endoplasmic reticulum associated degradation of the peptide binding domain and concentration of BiP. Mol Biol Cell 14:3437-3448
62. Vaupel PW (1994) Tissue pH distribution and bioenergetic status of tumours. Lecture no. 23, Ernst Schering Research Foundation, Berlin, Germany
63. Vaupel P (1992) Physiological properties of malignant tumours. NMR Biomed 5:220-225
64. Gullino PM, Grantham FH, Courtney AH (1967) Glucose consumption by transplanted tumors in vivo. Cancer Res 27:1031-1040
65. Gatenby RA (1995) The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Res 55:4151-4156
66. Rofe AM, Bourgeois CS, Bais R, Conyers RA (1988) The effect of tumour-bearing on 2-deoxy[U-14C]glucose uptake in normal and neoplastic tissues in the rat. Biochem J 253:603-606
67. Heacock CS, Sutherland RM (1990) Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 62:217-225
68. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
69. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J (1996) Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 56:1164-1167
70. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72
71. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H (2000) Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 60:6201-6207
72. Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R (1999) An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 96:3047-3052
73. Hue L, Rousseau GG (1993) Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes. Adv Enzyme Regul 33:97-110
74. Vora S, Halper JP, Knowles DM (1985) Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation-and progression-linked discriminants of malignancy. Cancer Res 45:2993-3001
75. Mathupala SP, Heese C, Pedersen PL (1997) Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem 271:22776-22780
76. Lewis BC, Shim H, Li Q, Wu CS, Lee LA, Maity A, Dang CV (1997) Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol Cell Biol 17:4967-4978
77. Valera A, Pujol A, Gregori X, Riu E, Visa J, Bosch F (1995) Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J 9:1067-1078
78. Le QT, Denko NC, Giaccia AJ (2004) Hypoxic gene expression and metastasis. Cancer Metastasis Rev 23:293-310
79. Gazit G, Lu J, Lee AS (1999) De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 54:135-146
80. Ramsay RG, Ciznadija D, Mantamadiotis T, Anderson R, Pearson R (2005) Expression of stress response protein glucose regulated protein-78 mediated by c-Myb. Int J Biochem Cell Biol 37:1254-1268
81. Song MS, Park YK, Lee JH, Park K (2001) Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumour cells through a protein kinase C-ε/ERK/AP-1 signalling cascade. Cancer Res 61:8322-8330
82. Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, Kennedy KA, Patierno SR (2000) Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 59:15-26
83. Ménoret A, Meflah K, Le Pendu J (1994) Expression of the 100KD glucose regulated protein (GRP100/Endoplasmin) is associated with tumourigenicity in a model rat colon adenocarcinomas. Int J Cancer 56:400-440
84. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto N, Yamamoto M (2003) Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38:605-614
85. Chen X, Ding Y, Chang-Gong L, Mikhail S, Yang CS (2002) Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans. Carcinogenesis 23:123-130
86. Takahashi S, Suzuki S, Inaguma S, Ikeda Y, Cho YM, Nishiyama N, Fujita T, Inoue T, Hioki T, Sugimura Y, Ushijima T, Shirai T (2002) Down regulation of human X-box Binding Protein 1 (hXBP-1) expression correlates with tumour progression in human prostate cancers. Prostate 50:154-161
87. Kudo Y, Takata T, Ogawa I, Kaneda T, Sato S, Takekoshi T, Zhao M, Miyauchi M, Nikai H (2000) p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res 6:916-923
88. Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV (1998) Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res 58:4342-4348
89. Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4:349-360
90. Diehl JA, Zindy F, Sherr CJ (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11:957-972
91. Li B, Dou QP (2000) Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci USA 97:3850-3855
92. Chen C, Dudenhausen EE, Pan YX, Zhong C, Kilberg MS (2004) Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J Biol Chem 279:27948-27956
93. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21:1249-1259
94. Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933
95. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 9:423-432
96. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23:2134-2145
97. Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ (1999) Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 59:6046-6051
98. Qu L, Huang S, Baltzis D, Rivas-Estilla AM, Pluquet O, Hatzoglou M, Koumenis C, Taya Y, Yoshimura A, Koromilas AE (2004) Endoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3β. Genes Dev 18:261-277
99. Roybal CN, Yang S, Sun CW, Hurtado D, Vander Jagt DL, Townes TM, Abcouwer SF (2004) Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 279:14844-14852
100. Ikeda J, Kaneda S, Kuwabara K, Ogawa S, Kobayashi T, Matsumoto M, Yura T, Yanagi H (1997) Cloning and expression of cDNA encoding the human 150 kDa oxygen-regulated protein, ORP150. Biochem Biophys Res Commun 230:94-99
101. Ozawa K, Kondo T, Hori O, Kitao Y, Stern DM, Eisenmenger W, Ogawa S, Ohshima T (2001) Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest 108:41-50
102. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4:966-977
103. Steel GJ, Fullerton DM, Tyson JR, Stirling CJ (2004) Coordinated activation of Hsp70 chaperones. Science 303:98-101
104. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener DR, Wek RC (2003) Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-κB in response to diverse cellular stresses. Mol Cell Biol 23:5651-5663
105. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT, Koong AC (2004) XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res 64:5943-5947
106. Wang JC (1996) DNA topoisomerases. Ann Rev Biochem 65:635-692
107. Osheroff N (1998) DNA topoisomerases. Biochim Biophys Acta 1400:1-2
108. Chen AY, Liu LF (1994) DNA topoisomerases essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218
109. Nitiss JL, Beck WT (1996) Anti topoisomerase drug action and resistance. Eur J Cancer 32:958-966
110. Shen J, Hughes C, Chao C, Cai J, Bartels C, Gessner T, Subjeck J (1987) Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc Natl Acad Sci USA 84:3278-3282
111. Shen JW, Subjeck JR, Lock RB, Ross WE (1989) Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response. Mol Cell Biol 9:3284-3291
112. Hughes CS, Shen JW, Subjeck JR (1989) Resistance to etoposide (VP-16) induced by three glucose related stresses in Chinese hamster ovary cells. Cancer Res 49:4452-4454
113. Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL (1992) Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52:3648-3654
114. Chatterjee S, Cheng MF, Berger RB, Berger SJ, Berger NA (1995) Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide. Cancer Res 55:868-873
115. Rao RV, Peel A, Logvinova A, del Rio G, Hermel E, Yokota T, Goldsmith PC, Ellerby LM, Ellerby HM, Bredesen DE (2002) Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514:122-128
116. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS (2003) Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J Biol Chem 278:20915-20924
117. Swedlow JR, Hirano T (2003) The making of the mitotic chromosome: modern insights into classical questions. Mol Cell 11:557-569
118. Yun J, Tomida A, Andoh T, Tsuruo T (2004) Interaction between glucose-regulated destruction domain of DNA topoisomerase IIα and MPN domain of Jab1/CSN5. J Biol Chem 279:31296-31303
119. Oono K, Yoneda T, Manabe T, Yamagishi S, Matsuda S, Hitomi J, Miyata S, Mizuno T, Imaizumi K, Katayama T, Tohyama M (2004) JAB1 participates in unfolded protein responses by association and dissociation with IRE1. Neurochem Int 45:765-772
120. Chatterjee S, Hirota H, Belfi CA, Berger SJ, Berger NA (1997) Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78. Cancer Res 57:5112-5116
121. Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA (1999) Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Biochem Biophys Res Commun 257:361-368
122. Mandic A, Hansson J, Linder S, Shoshan MC (2003) Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278:9100-9106
123. Morris JA, Dorner AJ, Edwards CA, Hendershot LM, Kaufman RJ (1997) Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins. J Biol Chem 272:4327-4334
124. Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH (2003) Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci USA 100:9946-9951
125. Chandler NM, Canete JJ, Callery MP (2004) Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine. J Gastrointest Surg 8:1072-1078
126. Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ (2004) The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo. Mol Cancer Ther 3:279-290
127. Mortenson MM, Schlieman MG, Virudachalam S, Bold RJ (2004) Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol 54:343-353
128. Ikezoe T, Yang Y, Saito T, Koeffler HP, Taguchi H (2004) Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells. Cancer Sci 95:271-275
129. Yang Y, Ikezoe T, Saito T, Kobayashi M, Koeffler HP, Taguchi H (2004) Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling. Cancer Sci 95:176-180
130. Nawrocki ST, Sweeney-Gotsch B, Takamori R, McConkey DJ (2004) The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. Mol Cancer Ther 3:59-70
131. Adachi M, Zhang Y, Zhao X, Minami T, Kawamura R, Hinoda Y, Imai K (2004) Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells. Clin Cancer Res 10:3853-3862
132. Denlinger CE, Keller MD, Mayo MW, Broad RM, Jones DR (2004) Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. J Thorac Cardiovasc Surg 127:1078-1086
133. Dy GK, Thomas JP, Wilding G, Bruzek L, Mandrekar S, Erlichman C, Alberti D, Binger K, Pitot HC, Alberts SR, Hanson LJ, Marnocha R, Tutsch K, Kaufmann SH, Adjei AA (2005) A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer. Clin Cancer Res 11:3410-3416
134. Davis NB, Taber DA, Ansari RH, Ryan CW, George C, Vokes EE, Vogelzang NJ, Stadler WM (2004) Phase II Trial of PS-341 in patients with renal cell cancer: a University of Chicago Phase II Consortium Study. J Clin Oncol 22:115-119
135. Shah MH, Young D, Kindler HL, Webb I, Kleiber B, Wright J, Grever M (2004) Phase II study of the proteasome inhibitor Bortezomib (PS-341) in patients with metastatic neuroendocrine tumours. Clin Cancer Res 10:6111-6118
136. Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, Hayakawa Y, Tsuro T, Shin-ya K (2004) Effect on tumour cells of blocking survival response to glucose deprivation. J Natl Cancer Inst 96:1300-1310